Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis
Haas, S.
Deutsche Medizinische Wochenschrift 120(14): 503
1995
ISSN/ISBN: 0012-0472 PMID: 7712947 Document Number: 441780
Document emailed within 1 workday
Related Documents
Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Forbes, C.D. 1989: Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin British Journal of Clinical Practice 43(11): 396-400
Koppenhagen, K.; Tröster, E.; Matthes, M.; Häring, R. 1990: Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1163-1166
Yang, Z.; Liu, X.; Dai, S.; Liu, K.; Zhang, Y.; Sun, J.; Yin, X. 2010: Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(9): 1058-1061
Schwarz, B.; Mittelmeier, H. 1988: Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery Aktuelle Traumatologie 18(5): 226-232
Uzan, A.; Clairefond, P.; Mardiguian, J.; Trillou, M.; Le Fur, G.; Mestre, M. 1985: Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169) Annales Pharmaceutiques Francaises 43(6): 539-546
Akanmu, A.S.; Nnodu, O.E.; Giwa, S.O.; Salako, L.A.; Akinsete, I.; Adebule, G.T.; Adekoya-Cole, T.O.; Odunubi, O.O. 2004: Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery African Journal of Medicine and Medical Sciences 33(4): 335-340
Wille-Jørgensen, P.A. 1991: Sandoparin dihydroergotamine. A combination preparation for prevention of thrombosis Ugeskrift for Laeger 153(34): 2370-2372
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Vallano, A.; Arnau, J.M.; Vallés, J.A. 1991: Prophylaxis of venous thrombosis and low-molecular-weight heparin Medicina Clinica 97(7): 272-275
2003: Low molecular weight heparin certoparin. Clear simplification of thrombosis treatment MMW Fortschritte der Medizin 145(19): Suppl. 1-3
Nesvold, A.; Ly, B.; Abildgaard, U.; Stiris, M. 1991: Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(27): 3296-3297
Alonso Martínez, J.L.; Abínzano Guillén, M.L.; Urbieta Echezarreta, M.A.; Annichérico Sánchez, F.J.; Fernández Ladrón, V.; García Sanchotena, J.L. 2008: Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis Anales de Medicina Interna 25(1): 4-8
Stephan, D.; Welsch, M.; Chapatte, D.; Weltin, D.; Imbs, J.L. 1999: Deep venous thrombosis during pregnancy: long-term treatment with low molecular weight heparin Presse Medicale 28(34): 1880
Broyer, M.; Gagnadoux, M.F.; Sierro, A.; Fischer, A.M.; Niaudet, P. 1991: Preventive treatment of vascular thrombosis after kidney transplantation in children with low molecular weight heparin Transplantation Proceedings 23(1 Pt 2): 1384-1385
Savage, K.J.; Wells, P.S.; Schulz, V.; Goudie, D.; Morrow, B.; Cruickshank, M.; Kovacs, M.J. 1999: Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity Thrombosis and Haemostasis 82(3): 1008-1010
Labas, P.; Ohrádka, B.; Vladimír, J.; Cambal, M. 2000: The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression International Angiology: a Journal of the International Union of Angiology 19(4): 303-307